Remimazolam Versus Dexmedetomidine for Monitored Anesthesia Care in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial
Sung-woo Hyung, Myokyung Choi, Mee Young Chung, Wonjung Hwang · 2026
Read Remimazolam Versus Dexmedetomidine for Monitored Anesthesia Care in Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation: A Randomized Clinical Trial by Sung-woo Hyung, Myokyung Choi, Mee Young Chung, Wonjung Hwang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13607414.txt.
Description
Sung-woo Hyung and co-authors compare two sedatives for patients having a heart valve placed through the leg artery, in a 2026 trial. The procedure, called tf-TAVI, is often done with monitored anesthesia care rather than full anesthesia. Thirty-four patients were assigned evenly to remimazolam or dexmedetomidine. The main checks were drops in blood pressure needing treatment and the total dose of pressure-raising drugs.
Low-pressure episodes and drug doses did not differ clearly between groups. Brain oxygen readings ran higher with remimazolam at some time points. Blood carbon dioxide ran higher and acidity lower with remimazolam near key steps. Recovery was much faster on remimazolam, about fourteen minutes against thirty-two. Surgeons also asked for deeper sedation far less often in that group. The authors note the trial was small and call for larger confirmation.
Catalog record
| CREATOR | Sung-woo Hyung, Myokyung Choi, Mee Young Chung, Wonjung Hwang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |